Oral and intranasal platforms have proven effective in other infectious diseases such as, polio and influenza, by provoking localized IgA responses in the gut- or nasopharynx-associated lymphoid tissues (Boyaka, 2017). The gene discussed is CD79A; the disease is infectious disease.